Daiichi Sankyo Co., Ltd.

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new 3 horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases. For all other inquiries about Daiichi Sankyo such as products or careers, please visit our website www.daiichisankyo.com. Please see below for global employment opportunities: Daiichi Sankyo Europe: http://linkd.in/1C7vu7Z Daiichi Sankyo Inc: http://linkd.in/1aDztT4 Daiichi Sankyo Spain: http://linkd.in/1DUavKt Daiichi Sankyo Germany: http://linkd.in/1GZA11G Daiichi Sankyo UK: http://linkd.in/1FwcGTo Daiichi Sankyo Switzerland: http://linkd.in/1GZA3GR Daiichi Sankyo France: http://linkd.in/1yPOAhu Daiichi Sankyo Brazil: http://linkd.in/1CMnnQO Daiichi Sankyo Ireland: http://linkd.in/1GZAbX2 Daiichi Sankyo Life Sciences Research Centre India: http://linkd.in/1DUbev1